Soffer S - Search Results

1

Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors.

Huang J, Moore J, Soffer S, Kim E, Rowe D, Manley CA, O'Toole K, Middlesworth W, Stolar C, Yamashiro D, Kandel J. Huang J, et al. Among authors: soffer s. J Pediatr Surg. 2001 Feb;36(2):357-61. doi: 10.1053/jpsu.2001.20716. J Pediatr Surg. 2001. PMID: 11172434

2

The nonoperative management of fistula-in-ano.

Rosen NG, Gibbs DL, Soffer SZ, Hong A, Sher M, Peña A. Rosen NG, et al. Among authors: soffer sz. J Pediatr Surg. 2000 Jun;35(6):938-9. doi: 10.1053/jpsu.2000.6931. J Pediatr Surg. 2000. PMID: 10873039

3

All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor.

Kim E, Moore J, Huang J, Soffer S, Manley CA, O'Toole K, Middlesworth W, Stolar CJ, Kandel JJ, Yamashiro DJ. Kim E, et al. Among authors: soffer s. J Pediatr Surg. 2001 Feb;36(2):287-90. doi: 10.1053/jpsu.2001.20691. J Pediatr Surg. 2001. PMID: 11172417

4

Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor.

Soffer SZ, Moore JT, Kim E, Huang J, Yokoi A, Manley C, O'Toole K, Stolar C, Middlesworth W, Yamashiro DJ, Kandel JJ. Soffer SZ, et al. J Pediatr Surg. 2001 Aug;36(8):1177-81. doi: 10.1053/jpsu.2001.25747. J Pediatr Surg. 2001. PMID: 11479851

5

Effective therapy of a vascular tumor of infancy with vincristine.

Moore J, Lee M, Garzon M, Soffer S, Kim E, Saouaf R, del Toro G, Yamashiro D, Kandel J. Moore J, et al. Among authors: soffer s. J Pediatr Surg. 2001 Aug;36(8):1273-6. doi: 10.1053/jpsu.2001.25793. J Pediatr Surg. 2001. PMID: 11479875

6

Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor.

Soffer SZ, Kim E, Moore JT, Huang J, Yokoi A, Manley C, O'Toole K, Middlesworth W, Stolar C, Yamashiro D, Kandel J. Soffer SZ, et al. J Pediatr Surg. 2001 Dec;36(12):1781-4. doi: 10.1053/jpsu.2001.28823. J Pediatr Surg. 2001. PMID: 11733906

7

Distinct response of experimental neuroblastoma to combination antiangiogenic strategies.

Kim ES, Soffer SZ, Huang J, McCrudden KW, Yokoi A, Manley CA, Middlesworth W, Kandel JJ, Yamashiro DJ. Kim ES, et al. Among authors: soffer sz. J Pediatr Surg. 2002 Mar;37(3):518-22. doi: 10.1053/jpsu.2002.30855. J Pediatr Surg. 2002. PMID: 11877680

8

p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease.

Huang J, Soffer SZ, Kim ES, Yokoi A, Moore JT, McCrudden KW, Manley C, Middlesworth W, O'Toole K, Stolar C, Yamashiro DJ, Kandel JJ. Huang J, et al. Among authors: soffer sz. J Pediatr Surg. 2002 Mar;37(3):523-7. doi: 10.1053/jpsu.2002.30858. J Pediatr Surg. 2002. PMID: 11877681

9

Resistance of a VEGF-producing tumor to anti-VEGF antibody: unimpeded growth of human rhabdoid tumor xenografts.

Soffer SZ, Kim E, Huang J, McCrudden K, Yokoi A, Moore JT, Manley C, O'Toole K, Middlesworth W, Stolar C, Yamashiro DJ, Kandel JJ. Soffer SZ, et al. J Pediatr Surg. 2002 Mar;37(3):528-32. doi: 10.1053/jpsu.2002.30859. J Pediatr Surg. 2002. PMID: 11877682

10

Topotecan is anti-angiogenic in experimental hepatoblastoma.

McCrudden KW, Yokoi A, Thosani A, Soffer SZ, Kim ES, Huang J, Manley C, O'toole K, Yamashiro DJ, Kandel JJ, Middlesworth W. McCrudden KW, et al. Among authors: soffer sz. J Pediatr Surg. 2002 Jun;37(6):857-61. doi: 10.1053/jpsu.2002.32887. J Pediatr Surg. 2002. PMID: 12037749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters